TYRATyra Biosciences, Inc.
What is the market doing?
No clear lean: insiders net buying, but in a downtrend (−33% vs 200-day) and a crowded short (+16% of shares).
In a downtrend, below its 50- and 200-day averages. Oversold (RSI 15). Price is −33% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 8, 2026.
A crowded short, settled Sep 15, 2026, about a week of normal trading to cover. Up 4.6% since the previous count, unchanged over three months.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How TYRA is trading
Tyra Biosciences, Inc. is +59% over the past year while the S&P 500 is +18%: 41 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −33%
vs 200-day average · a clear downtrend
- RSI (14)
- 15
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 50%
Below its 52-week high
Details›
- Last close2026-10-09
- $19.91
- 1 monthS&P 500 +2.7%
- −15%
- 1 yearS&P 500 +18%
- +59%
- vs 50-day average$24.84
- −20%
- 52-week high
- $39.61
- 52-week low
- $12.54
- Annualised volatility
- 67%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $20K
| Year | Return |
|---|---|
| 2026 (year to date) | −24% |
| 2025 | +89% |
| 2024 | +0.36% |
| 2023 | +82% |
| 2022 | −46% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 3 of 5 | +10% |
| Feb | 5 | 3 of 5 | +11% |
| Mar | 5 | 2 of 5 | −2.3% |
| Apr | 5 | 2 of 5 | −7.3% |
| May | 5 | 1 of 5 | −5.4% |
| Jun | 5 | 3 of 5 | +3.7% |
| Jul | 5 | 3 of 5 | +18% |
| Aug | 5 | 3 of 5 | −7.1% |
| Sep | 5 | 3 of 5 | +4.9% |
| Oct | 6 | 2 of 6 | −5.7% |
| Nov | 5 | 4 of 5 | +10% |
| Dec | 5 | 3 of 5 | −2.4% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.